At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 604 enrolled
Drug / intervention
Zyppah Anti-snoring Appliancedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
In-Home Study of Intraoral Device for Reducing Snoring Among Habitual Snorers
In Brief
A Phase 3 clinical trial evaluating Zyppah Anti-snoring Appliance for Snoring. Completed, enrolled 604 participants across 1 site.
Detailed Summary
Online patient registration to participate in clinical trial to test OTC mouthpiece that controls position of the tongue to reduce snoring.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSnoring
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
201820192020202120222023202420252026
Enrollment StartApr 2017
First PostedApr 2017
Primary CompletionMay 2017
Study CompletionAug 2017
TodayJul 2026
First PostedApr 25, 2017
Enrollment StartApr 7, 2017
Primary CompletionMay 3, 2017
Study CompletionAug 10, 2017
TodayJul 2, 2026
Enrollment to primary: 26 daysPosted 9.2 years ago
Interventions
Zyppah Anti-snoring Appliancedevice
Use of an OTC mouth guard at night to prevent snoring